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Smumary In order to assess the stage of colorectal tumorigenesis at which chromosome 8p loss of
heterozygosity (LOH) occurs, 56 sporadic adenomas were examined for LOH at four polymorphic loci which
show frequent LOH in carcinomas. LOH was found in only 5 out of 51 (9.8%) informative adenomas,
whereas studies with the same markers in 85 informative carcinomas showed a LOH of 45%. The adenomas
showing LOH were all in the 'high-risk' clinicopathological category, being 10 mm or more in diameter and
showing tubulovillous architecture. It is concluded that the chromosome 8p locus is involved preferentially in
the development of carcinomas rather than adenomas.
The development of colorectal cancer incorporates several
discrete genetic events. Some are largely restricted to car-
cinomas, whereas others are found in both adenomas and
carcinomas. Inactivaton of tumour-suppressor genes APC
and DCC by mutation or loss occurs in the majority of both
colorectal adenomas and carcinomas (Fearon & Vogelstein,
1990; Powell et al., 1992). Similarly, activating mutations in
K-ras oncogene occur with nearly identical frequency in car-
cinomas and larger adenomas (Fearon & Vogelstein, 1990).
Presumably such lesions affect the expansion of neoplastic
populations without directly conferring a malignant
phenotype. In contrast, the p53 gene is inactivated in 75% of
colorectal cancers but is not abnormal in adenomas except
those displaying features of severe dysplasia, and this gene
would appear to have a major role initiating malignant
behaviour (Baker et al., 1990; Kikuchi-Yanoshita et al., 1992;
Carder et al., 1993). Such genetic lesions are of interest
because they suggest the existence of genes involved in the
critical transition from benign to malignant growth. We
(Cunningham et al., 1993) and others (Fujiwara et al., 1993)
have recently identified a region on chromosome 8p that
exhibits frequent LOH in colorectal cancer, indicating a fur-
ther putative oncosuppressor locus or loci. In this paper we
assess the frequency of LOH at this region in sporadic col-
orectal adenomas to determine at what stage in evolution of
colorectal tumours this molecular lesion exerts preferential
selective advantage.
Loss of heterozygosity affecting chromosome 8p is found
in over 50% of colorectal cancers (Cunningham et al., 1993).
A similar frequency of chromosome 8p LOH has been deter-
mined in bladder, prostate, lung and hepatocellular cancer
(Bergenheim et al., 1991; Emi et al., 1992; Knowles et al.,
1993). In bladder and hepatocellular cancer, there is a cor-
relation between chromosome 8p LOH and advanced tumour
stage and grade (Emi et al., 1993; Knowles et al., 1993). In
colorectal cancer we were unable to identify a correlation
between chromosome 8p LOH and tumour site or Dukes
stage (Cunningham et al., 1993), although such an associa-
tion with cdnicopathological stage has been suggested by
others (Fujiwara et al., 1993). In addition, the possibility of
two separate chromosome 8p colorectal oncosuppressor loci
has been proposed (Fujiwara et al., 1993). This work add-
resses the question of the role of the chromosome 8p locus or
loci in tumorigenesis by determining the frequency of loss of
heterozygosity in 56 sporadic colorectal adenomas at four
chromosome 8p loci which have shown a high frequency of
LOH in colorectal cancers. The adenomas were gathered
from both cancer-bearing and cancer-free bowel. The results
suggest preferential involvement of the chromosome 8p locus
in the later stages of colorectal tumorigenesis.
Materhk and methods
DNA was purified from 56 sporadic colorectal adenomas and
matched normal tissue, either blood or histologically normal
colonic mucosa, obtained from 49 individuals. Thirty-three
adenomas were colected from fresh colorectal specimens
resected for malignant disease. Of the remainder, 16 were
removed endoscopically from cancer-free bowel as part of a
presymptomatic screening programme.
Analysis ofLOH using (CA). repeat polymorphisns
Three microsatellite (CA). repeat markers were employed
which had shown a high frequency of LOH in colorectal
cancers. ANK1 (Polymeropoulos et al., 1991) maps to
8p2l -p1 1.2, LPL3GT (Tomforhde et al., 1992) maps to 8p22
and D8S137 (Tomforhde et al., 1992) to 8p2l-pl2.
Polymerase chain reactions comprised 251lI volumes with
200 iM of each nucleotide, 0.625units of Taq polymerase
enzyme (Promega, UK) 2.5 pi of buffer (Promega, UK)
2.5 mM magnesium sulphate, 50 ng of each primer and 50 ng
of template DNA. In each reaction 10 pg of one primer was
end labelled with [a2PJdATP, using T4 polynucleotide
kinase. PCR reactions were carried out in microwell plates in
an Omnigene thermal cycler (Hybaid, Middklsex, UK) and
consisted of 29 cycles of 95'C for 1 min, 55'C for 1 min and
72'C for 2 min. A 10 i1l aliquot of loading buffer (95%
deionised formamide, 10mM disodium EDTA, 0.1% xylene
cyanol and 0.1% bromophenol blue) was added to each
reaction and 4 gl aliquots were run on 6% denaturing
polyacrylamide gels. Gels were dried and exposed to Kodak
X-OMAT AR film for 24 h. Autoradiographs were assessed
visually by two observers.
HindIIIpolymorphism detected by PCR
Hindlll polymorphism in intron 8 of the lipoprotein lipase
gene (8p.22) was demonstrated by PCR under conditions
described by Bruin et al. (1991). PCR products were digested
with HindII1, separated by electrophoresis on 2% agarose
gels, stained with ethidium bromide and visualised under
ultraviolet light.
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Results
We have previously reported LOH analysis of three of the
markers used in this analysis (ANKI, LPL3GT and
LPLHdIII) in 120 colorectal cancers (Cunningham et al.,
1993). In this study we further analysed the same colorectal
cancers at the D8S137 locus and found a frequency of LOH
of 50% (27 out of 54 informative cases). The percentage
LOH for each of these markers in colorectal cancers and
adenomas is presented in Figure 1. Of the 56 adenomas, 51
were informative with at least one marker, and of these only
five (9.8%) showed loss of heterozygosity. In contrast, when
used in the study of 120 colorectal cancers, these four
markers detected a LOH in 38 out of 85 informative cases
(45%), a difference that is highly significant (X = 16.38;
P<0.00005). The adenomas consisted of 35 tubulovillous
lesions (mean size 27 mm, range 6-80mm), 20 tubular lesions
(mean size 14 mm, range 5-20 mm) and one villous lesion
(15 mm). The five shown to have LOH at chromosome 8p
were tubulovillous adenomas of 10 mm or more in diameter.
Chromosome 8p LOH was not detected in any of the 10
adenomas less than 10 mm in diameter, seven of which were
tubular adenomas and three tubulovillous lesions.
We have detected loss of heterozygosity in less than 10%
(5/51) of adenomas examined in this series, which is
significantly less than the frequency of LOH (45%) in a
similar analysis of 85 informative malignant tumours. As
detailed above, this was a mixed group ofadenomas in terms
of size and histological types. The five lesions showing LOH
were all tubulovillous adenomas, 10 mm or more in diameter.
Although the numbers are small, chromosome 8p LOH was
only detected in this study in the subgroup of adenomas
which are known to carry a greater malignant potential. We
are unaware of any study of chromosome 8p LOH in spor-
adic adenomas. However, a recent report of adenomas aris-
ing in familial adenomatous polyposis (FAP) describes no
chromosome 8p LOH in 37 informative adenomas from two
individuals (Ichii et al., 1993). Our series is likely to have
included a higher proportion of tubulovillous lesions than
this group of FAP adenomas, and this may account for the
presence, albeit rare, ofchromosome 8p LOH in the sporadic
lesions reported here. Overall, our data suggest that the
putative chromosome 8p tumour-suppressor gene is impor-
tant in the later stages of tumorigenesis in the colon and
rectum. This pattern is similar to that noted for the p53 gene
(Baker et al., 1990; Kikuchi-Yanoshita et al., 1992) and
strikingly different to that found in APC, DCC and K-ras
(Fearon & Vogelstein, 1990; Powell et al., 1992).
Thus, LOH at the 8p locus appears to be one of a select
group of acquired genetic lesions preferentially associated
with malignant change in colorectal epithelium. Others in-
clude abnormalities of p53 and aneuploidy. In several cell
lineages, including colorectal mucosa, abnormalities of p53
are known to induce instability of the genome, of which
Referes
AALTONEN, L.A., PELTOMAKI, P.. LEACH, F.S., SISTONEN. P., PYL-
KKANEN, L_. MECKLIN, J.-P-. JARVINEN, H., POWELL, S., JEN, J.,
HAMILTON, SR.. PETERSEN, G.M., KINZLER, K, VOGELSTEIN,
B. & DE LA CHAPELLE, A. (1993). Clues to the pathogenesis of
familial colon cancer. Science, 260 812-816.
BAKER, SJ., PRELSINGER, J., MILBURN, J., PARASKEVA, C., MAR-
KOWIZ S, WILLSON, J.K.V., HAMILTON, S. & VOGELSTEIN, B.
(1990). p53 gene mutations occur in combination with 17p allelic
deletions as late events in colorectal tumorigenesis. Cancer Res.,
50, 7717-7722.
BERGENHEIM, U.S.R.. KUNIMI, K., COLLINS. P. & EKCMAN, P.
(1991). Deletion mapping of chromosomes 8, 10, and 16 in
human prostatic cancer. Genes Chrom. Concer, 3, 215-220.
60
50
iS _ 2715 21/48 38/W





ANKi DSS137 LPL3GT LPLHcIIlCumulative
Chromosone 8p Loci
Fiwe 1 Chromosome 8p LOH in sporadic colorectal adenomas
(-) and colorectal cancers (0). Frequency of LOH is presented
for both carcinomas and adenomas at each locus, together with
the cumulative data at all four. These are all significnt: ANKI,
P<0.001; D8S137, P<0.0005; LPL3GT, P<0.002; LPLHdIIl,
P<0.05; cumulative, P<0.00005. Number of cases showing
LOH/number of informative cases is shown above bars.
aneuploidy is an example (Livingstone et al., 1992; Carder et
al., 1993). A further lesion, at the hMSH2 gene on chromo-
some 2p, is associated with hereditary non-polyposis colorec-
tal cancer (HNPCC), a familial disorder characterised by the
development of carcinoma without prior proliferation of
benign lesions (Fishel et al., 1993; Leach et al., 1993). This
also appears to involve infidelity in DNA replication, charac-
terised by variability in the length of microsatellite repeats
between normal and tumour DNA (Aaltonen et al., 1993;
Ionov et al., 1993; Thibodeau et al., 1993). Such instability
has been recorded in up to 28% (Thibodeau et al., 1993) of
apparently sporadic colorectal cancers but is rare in
adenomas (Young et al., 1993). At the three microsatellite
loci examined in this paper we detected instability in only
one adenoma, an 18-mm-diameter tubulovillous lesion
removed from non-cancer-bearing bowel. Published data
indicate that genomic instability manifest as either aneu-
ploidy or microsatellite instability is commonly acquired in
malignant colorectal lesions. It is interesting to speculate that
the defects in the putative 8p oncosuppressor may also relax
the fidelity of DNA or chromosomal replication or impair
DNA repair mechanisms.
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